It does not burden the skin, does not cause blackheads, does not dry the skin, does not create a mask effect.
HIGH TOLERANCE AND EFFICACY
Recommended for overactive skin with dilated capillaries, which requires color balance and hiding imperfections in the form of dilated capillaries, telangiectasia (spider veins), excessive tendency to redness, persistent, paroxysmal and emotional erythema, rosacea, uneven skin structure, swelling, eye shadow.
Recommended to strengthen the blood vessels and reduce the tendency to intensify erythema and irritation.
The foundation has a double (hybrid) effect on couperose skin. It effectively conceals redness, visible capillaries and erythema thanks to mineral piments while simultaneously strenghtening the blood vessels through the anti-redness effect of the Inno-tetrapeptide and Antileu-calm system, which is a known inhibitor of pro-inflammatory molecule release.
The foundation minimizes the appearance of all kinds of couperose skin symptoms, helping to prevent them from developing and becoming exacerbated, while also counteracting dermal hypersensitivity. It blends perfectly into the skin, giving it an even tone and texture, while the mattifying molecules provide coverage.
Hyaluronic acid moisturizes the skin, making it firmer. The foundation is non-comedogenic and does not overlod the skin, create a mask-like effect, or cause excessive skin dryness. UVA/UVB filters protect the skin from environmental agressors.
Dermocosmetic for everyday use.
The fluid should be evenly spread over the face and allowed to absorb.
- Vitamin E
- UV filters
- hyaluronic acid
- golden algae (Laminaria Ochroleuca Extract)
HIGH TOLERANCE AND EFFECTIVENESS DERMATOLOGICALLY TESTED
ADVANCED FORMULA DESIGNED FOR VERY SENSITIVE SKIN
Efficacy proven in dermatological tests on skin with capillary problems:*
- 100% minimizes blood vessels appearance
- 97% evens out the skin tone
- 93% reducess redness
- 86% prevents occasional redness
- 86% smooths out the skin
- 90% eliminates signs of fatigue
*In vivo tests at the Dr Irena Eris Centre for Science and Research after 2 weeks of use.